PyInvesting

Market research

4570.TSE Immuno-Biological Laboratories Co., Ltd

TSE JPY Healthcare

Latest close

— —

Loading market data…

Test a moving-average rule with historical data.

Market facts
Market cap
10B
P/E ratio
26.85
Analyst target
Not available
Dividend yield
0.6%
Beta
-0.06

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 6 months ago

Immuno-Biological Laboratories Co., Ltd is currently in a long term downtrend where the price is trading 5.7% below its 200 day moving average.

From a valuation standpoint, the stock is 88.4% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 8.2.

Immuno-Biological Laboratories Co., Ltd's total revenue rose by 4.8% to $167M since the same quarter in the previous year.

Its net income has increased by 11.6% to $-73M since the same quarter in the previous year.

Based on the above factors, Immuno-Biological Laboratories Co., Ltd gets an overall score of 3/5.